SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-17-002942
Filing Date
2017-04-26
Accepted
2017-04-26 17:15:18
Documents
8
Period of Report
2017-04-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bpmx-20170426x8k.htm 8-K 56022
2 EX-4.1 bpmx-20170426ex4170f596e.htm EX-4.1 144971
3 EX-5.1 bpmx-20170426ex51e65df74.htm EX-5.1 24809
4 EX-10.1 bpmx-20170426ex10164239d.htm EX-10.1 272759
5 EX-10.2 bpmx-20170426ex102ab73eb.htm EX-10.2 46282
6 EX-99.1 bpmx-20170426ex9914ec4e1.htm EX-99.1 12331
7 GRAPHIC bpmx20170426ex102ab73eb001.jpg GRAPHIC 31877
8 GRAPHIC bpmx20170426ex9914ec4e1001.jpg GRAPHIC 7098
  Complete submission text file 0001558370-17-002942.txt   610202
Mailing Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025
Business Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: 8-K | Act: 34 | File No.: 001-37411 | Film No.: 17785394
SIC: 2834 Pharmaceutical Preparations